Tema ETF Trust · net assets $211M · 59 holdings as of August 31, 2026. Monthly N-PORT disclosure: the full book, not just equities.
EC: 99.6% · STIV: 0.4%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $7.38M | $9.61M | $4.71M |
| Reinvestment | $0 | $0 | $0 |
| Redemptions | $8.05M | $3.78M | $0 |
| Net realized gain (non-derivative) | $4.89M | $3.13M | $1.08M |
| Net unrealized appreciation (non-derivative) | $9.72M | -$5.68M | $12M |
The three months of the reporting period, as filed; month 3 ends August 31, 2026.
| Holding | Value | % of net assets |
|---|---|---|
| Revolution Medicines Inc EC | $12.7M | 6.02% |
| Eli Lilly & Co EC | $10.9M | 5.15% |
| Cogent Biosciences Inc EC | $9.92M | 4.70% |
| Roche Holding Ag EC | $8.81M | 4.17% |
| Novartis Ag EC | $8M | 3.79% |
| Bristol-myers Squibb Co EC | $7.54M | 3.57% |
| Merck & Co Inc EC | $7.52M | 3.56% |
| Abbvie Inc EC | $7.01M | 3.32% |
| Halozyme Therapeutics Inc EC | $6.73M | 3.19% |
| Beone Medicines Ltd EC | $6.71M | 3.18% |
| Johnson & Johnson EC | $6.53M | 3.09% |
| Immunome Inc EC | $6.33M | 3.00% |
| Genmab A/s EC | $6.08M | 2.88% |
| Cg Oncology Inc EC | $5.83M | 2.76% |
| Ideaya Biosciences Inc EC | $5.71M | 2.70% |
| Exelixis Inc EC | $5.54M | 2.63% |
| Bridgebio Pharma Inc EC | $4.92M | 2.33% |
| Amgen Inc EC | $4.34M | 2.06% |
| Enliven Therapeutics Inc EC | $4.31M | 2.04% |
| Astrazeneca PLC EC | $4.21M | 2.00% |
| Legend Biotech Corp EC | $4.11M | 1.95% |
| Zai Lab Ltd EC | $4.11M | 1.95% |
| Celcuity Inc EC | $3.82M | 1.81% |
| Erasca Inc EC | $3.72M | 1.76% |
| Relay Therapeutics Inc EC | $3.4M | 1.61% |
| Iovance Biotherapeutics Inc EC | $3.3M | 1.56% |
| Zymeworks Inc EC | $3.25M | 1.54% |
| Nuvation Bio Inc EC | $2.77M | 1.31% |
| Urogen Pharma Ltd EC | $2.64M | 1.25% |
| Arcus Biosciences Inc EC | $2.55M | 1.21% |
| Kura Oncology Inc EC | $2.17M | 1.03% |
| Gilead Sciences Inc EC | $2.14M | 1.02% |
| Tyra Biosciences Inc EC | $2.14M | 1.01% |
| Summit Therapeutics Inc EC | $2.04M | 0.97% |
| Corvus Pharmaceuticals Inc EC | $2M | 0.95% |
| Natera Inc EC | $1.96M | 0.93% |
| Tango Therapeutics Inc EC | $1.87M | 0.89% |
| Anaptysbio Inc EC | $1.87M | 0.88% |
| Immatics Nv EC | $1.71M | 0.81% |
| Replimune Group Inc EC | $1.66M | 0.79% |
| Immunocore Holdings PLC EC | $1.63M | 0.77% |
| Cullinan Therapeutics Inc EC | $1.45M | 0.69% |
| Guardant Health Inc EC | $1.4M | 0.66% |
| Oric Pharmaceuticals Inc EC | $1.29M | 0.61% |
| Candel Therapeutics Inc EC | $1.13M | 0.53% |
| Syndax Pharmaceuticals Inc EC | $1.06M | 0.50% |
| Janux Therapeutics Inc EC | $983K | 0.47% |
| Inhibrx Biosciences Inc EC | $898K | 0.43% |
| Olema Pharmaceuticals Inc EC | $871K | 0.41% |
| Bicara Therapeutics Inc EC | $867K | 0.41% |
| Bridgebio Oncology Therapeutic EC | $860K | 0.41% |
| Cytomx Therapeutics Inc EC | $811K | 0.38% |
| Arvinas Inc EC | $810K | 0.38% |
| First American Treasury Obliga STIV | $808K | 0.38% |
| First Tracks Biotherapeutics I EC | $804K | 0.38% |
| Moderna Inc EC | $736K | 0.35% |
| Adlai Nortye Group Ltd EC | $659K | 0.31% |
| Arrivent Biopharma Inc EC | $653K | 0.31% |
| Autolus Therapeutics PLC EC | $630K | 0.30% |
Loading...